PATENT CLAIM ANALYSIS

Application Number: 16283743
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "001000"]

Abstract:
The disclosed invention generally relates to treatment and/or prevention of symptoms associated with cannabinoid responsive diseases and disorders in subjects in need thereof, as well as the method of administering therapeutically-effective amount of a pharmaceutical compound containing cannabinoids. The disclosed invention further relates to pharmaceutical compounds for treating and/or preventing symptoms associated with said diseases and disorders.

Claim (Index 7):
The method of  claim 1 , where said compound is administered to a subject, where a single dose contains isomers of THC and CBD in the quantity ranging from 0.5 mg to 60 mg THC and 2.6 mg to 3,700 mg CBD.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 99.0
- Lexical Diversity: 1.42857
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15789998', '14163019', '12087847', '15554209', '10468041']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8212743635865885
- 35 USC 102 Novelty (BERT): 0.6033366427115592
- Combined Prediction Score: 0.7994805914990856
- Mean Citation Score: 437.63076
- Max Citation Score: 652.6821
- Similarity Product: 437.21590537816286

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test